Acotec Scientific Holdings Limited (HK:6669) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Acotec Scientific Holdings Limited has received approval from the PRC National Medical Products Administration for its Paclitaxel-Eluting Coronary Balloon Dilatation Catheter, AcoArt Camellia. Clinical trials demonstrated its superior efficacy and safety for treating coronary artery lesions compared to control groups. The company plans to launch marketing activities in China when appropriate.
For further insights into HK:6669 stock, check out TipRanks’ Stock Analysis page.
